You are here: Industry Insights > study

News List

Study finds drug reduces hearing loss in children with liver cancer pharmaceutical-technology
June 28, 2018
A study has found that a new drug sodium thiosulphate (STS) can reduce hearing loss in children treated for hepatoblastoma, a childhood liver cancer.
Study shows almost half of UK women experience ‘serious trouble’ with contraception pharmaceutical-technology
June 28, 2018
A study by educational women’s health website Femedic records that 47% of women in the UK have had ‘serious trouble’ with their current or previous form of contraception and 16% said they did not receive adequate professional care when they were experienc
Study finds antioxidant-enriched vitamin reduces respiratory illnesses in patients with CF worldpharmanews
June 05, 2018
Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado School of Medicine have found that taking a specially formulated antioxidant-enriched multivitamin may decrease respiratory illnesses in people with cystic fi
Study demonstrates new treatment for severe asthma worldpharmanews
June 05, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton
There's No 'Healthy Obesity' for Women, Study Finds drugs
May 31, 2018
Obese women who have been healthy for decades may still be on the path to heart problems, a new study suggests
Artificial intelligence outperforms dermatologists in detection of melanoma: study firstwordpharma
May 30, 2018
Study data published in the Annals of Oncology showed that when a deep learning convolutional neural network (CNN) was trained to identify skin cancer, it missed fewer melanomas and misdiagnosed benign nevi less often as malignant, when compared to a grou
Breast Cancer Patients May Shorten Herceptin Regimen: Study drugs
May 17, 2018
For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease.
PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study biospace
April 18, 2018
PharmaCyte Biotech, Inc.today announced that it has successfully completed a “multiple course ifosfamide study” required by the U.S. Food and Drug Administration (FDA).
Twenty percent of millennium generation is obese, study finds pharmatimes
December 12, 2017
Twenty percent of young people born in the UK at the turn of the century were obese by the age of 14, while a further 15 percent were found to be overweight, according to data from UCL’s Millennium Cohort Study.
First-ever study in the personalised treatment of rare cancers brings promising results pharmafile
October 19, 2017
The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual disease has wrought promising results, it has emerged.

Previous page 1 2 3 4 5 Next page